Clinical Trial Update: Argon Laser Peripheral Iridoplasty for Primary Angle Closure Glaucoma [Phase 3]

View source ↗

Summary

Phase 3 clinical trial is evaluating Argon Laser Peripheral Iridoplasty for primary angle-closure glaucoma; the current status of the study is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angle-closure Glaucoma

Snippet

Sponsor: Singapore National Eye Centre | Conditions: Glaucoma | Phase 3 | Status: UNKNOWN